Suchergebnisse - "Gupta, Neeraj"

PubPharm (651)

131

Can oscillometry be a substitute to spirometry in the indigent?

enthalten in: Lung India : official organ of Indian Chest Society | 2022

von Gupta, N.

132

An Audit of Mental Health Care Plans in Community Mental Health Services for Older Persons in Rural Communities in a State in Australia

enthalten in: The journal of behavioral health services & research | 2022

von Lecamwasam, D. | Gupta, N. | Battersby, M.

133

An Audit of Mental Health Care Plans in Community Mental Health Services for Older Persons in Rural Communities in a State in Australia

enthalten in: The journal of behavioral health services & research | 2022

von Lecamwasam, D. | Gupta, N. | Battersby, M.

134

Role of Regulatory Proteins Involved in Iron Homeostasis in Pulmonary Tuberculosis Patients and Their Household Contacts

enthalten in: Indian journal of clinical biochemistry : IJCB | 2022

von Panda, S. | Faisal, S. | Kumar, K. | +5

135

Tuberculosis with discordant drug resistance patterns- A diagnostic dilemma

enthalten in: The Indian journal of tuberculosis | 2022

von Gupta, N. | Ish, P.

136

High-k Dielectric Double Gate Junctionless (DG-JL) MOSFET for Ultra Low Power Applications- Analytical Model

enthalten in: Silicon | 2022

von Kumar, P. | Vashishath, M. | Gupta, N. | +1

137

High-k Dielectric Double Gate Junctionless (DG-JL) MOSFET for Ultra Low Power Applications- Analytical Model

enthalten in: Silicon | 2022

von Kumar, P. | Vashishath, M. | Gupta, N. | +1

138

Pharmacometric analyses and clinical evidence for brigatinib dosing in anaplastic lymphoma kinase‐positive non‐small cell lung cancer

enthalten in: British Journal of Clinical Pharmacology | 2022

von Gupta, N. | Hanley, M. | Sinha, V.

139

Assessment of Effects of Investigational TAK‐931, an Oral Cell Division Cycle 7 Kinase Inhibitor on the QTc Intervals in Patients With Advanced Solid Tumors

enthalten in: Clinical Pharmacology in Drug Development | 2022

von Zhou, X. | Diderichsen, P. | Gupta, N.

140

Mobocertinib Dose Rationale in Patients with Metastatic NSCLC with EGFR Exon 20 Insertions : Exposure–Response Analyses of a Pivotal Phase I/II Study

enthalten in: Clinical Pharmacology & Therapeutics | 2022

von Gupta, N. | Largajolli, A. | Witjes, H. | +5